Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PCTs urged to engage new providers:

This article was originally published in Clinica

Executive Summary

The UK's health ministry today announced plans to improve access to and extend GP services, in an initial package of measures that will provide the basis of further developments to be defined by the NHS Next Stage review. The review is being conducted by Professor Ara Darzi over the next year (see Clinica No 1263, p 2). The package of measures includes the creation of an improvement team to advise PCTs and GP practices on how to improve services, and the development of local action plans that should see PCTs "using their existing powers to invite new providers to offer high-quality services". The move is in response to a DoH-commissioned patient survey on access to GP services, which despite a generally positive appraisal, found "some significant pockets of dissatisfaction".

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT048545

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel